Meningococcal ACIP Vaccine Recommendations

as Published in Morbidity and Mortality Weekly Report (MMWR)

CURRENT Meningococcal Vaccine Recommendations

• MMWR, May 19, 2017, Vol 66 #19
  Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016
  Print version [5 pages]
• MMWR, November 4, 2016, Vol 65 #43
  Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016
  Print version [6 pages]
• MMWR, October 23, 2015, Vol 64 #41
  Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015
  Print version [24 pages]
• MMWR, June 12, 2015, Vol 64 #22
  Use of Serogroup B Meningococcal (MenB) Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
  Print version [16 pages]
• MMWR, June 20, 2014, Vol 63 #24
  Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk, 2013
  Print version [16 pages]
• MMWR, March 22, 2013, Vol 62, #RR02
  Prevention and Control of Meningococcal Disease
  Print version [32 pages]
• See also:
  • ACIP-VFC Resolution

ARCHIVED Historical Meningococcal Immunization Publications

For your convenience, these archived publications can be used for historical and research purposes.

• MMWR, January 25, 2013, Vol 62, #3
  Infant Meningococcal Vaccination: ACIP Recommendations and Rationale
  Print version [32 pages]
• MMWR, October 14, 2011, Vol 60, #40
  Recommendation of the ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
  Print version [2.03MB, 36 pages]
• MMWR, August 5, 2011, Vol 60, #30
  Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — ACIP, 2011
  Print version [1.12MB, 36 pages]
• MMWR, January 28, 2011, Vol 60, #03
  Updated Recommendations for Use of Meningococcal Conjugate Vaccines — ACIP, 2010
  Print version [28 pages]
• MMWR, March 12, 2010, Vol 59, #09
  Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use — ACIP, 2010
  Print version [20 pages]
• MMWR, September 25, 2009, Vol 58, #37
  Updated Recommendation from the ACIP for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
  Print version [1.49MB, 32 pages]
• MMWR, May 2, 2008, Vol 57, #17
  Report from ACIP: Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
  Print version [28 pages]
• MMWR, December 7, 2007, Vol 56, #48
  Notice to Readers: Recommendation from ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease
  Print version [24 pages]
• MMWR, August 10, 2007, Vol 56, #31
  Notice to Readers: Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine
  Print version [28 pages]
• MMWR, November 3, 2006, Vol 55, #43
  Notice to Readers: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11-12 Years
  Print version [23 pages]
• MMWR, September 22, 2006, Vol 55, #37
  Inadvertent Misadministration of Meningococcal Conjugate Vaccine — United States, June-August 2005
  Print version [24 pages]
• MMWR, May 26, 2006, Vol 55, #20
  Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11-12 Years
  Print version [32 pages]
• MMWR, May 27, 2005, Vol 54, #RR-07
  Prevention and Control of Meningococcal Disease
  Print version [28 pages]
• MMWR, Feb 14, 1997, Vol 46, #RR-5
  Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the ACIP
  (PDF not available)

Top of Page